BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28272283)

  • 1. DEXAMETHASONE INTRAVITREAL IMPLANT VS RANIBIZUMAB IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRACHYTHERAPY FOR CHOROIDAL MELANOMA.
    Russo A; Reibaldi M; Avitabile T; Uva MG; Franco LM; Gagliano C; Bonfiglio V; Spatola C; Privitera G; Longo A
    Retina; 2018 Apr; 38(4):788-794. PubMed ID: 28272283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
    Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
    Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal dexamethasone 0.7-mg implant for radiation macular edema after proton beam therapy for choroidal melanoma.
    Baillif S; Maschi C; Gastaud P; Caujolle JP
    Retina; 2013 Oct; 33(9):1784-90. PubMed ID: 23652581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion.
    Yuksel B; Karti O; Celik O; Kerci SG; Kusbeci T
    Clin Exp Optom; 2018 Jan; 101(1):116-122. PubMed ID: 28922697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
    Mason JO; Albert MA; Persaud TO; Vail RS
    Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
    Arıkan Yorgun M; Toklu Y; Mutlu M
    Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal aflibercept for the treatment of radiation-induced macular edema after ruthenium 106 plaque radiotherapy for choroidal melanoma.
    Fallico M; Reibaldi M; Avitabile T; Longo A; Bonfiglio V; Chronopoulos A; Caltabiano R; Spatola C; Russo A
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1547-1554. PubMed ID: 31081526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal dexamethasone implant in radiation-induced macular oedema.
    Frizziero L; Parrozzani R; Trainiti S; Pilotto E; Miglionico G; Pulze S; Midena E
    Br J Ophthalmol; 2017 Dec; 101(12):1699-1703. PubMed ID: 28404670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.
    Chiquet C; Dupuy C; Bron AM; Aptel F; Straub M; Isaico R; Romanet JP; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2095-102. PubMed ID: 25673251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.
    Manousaridis K; Peter S; Mennel S
    Int Ophthalmol; 2017 Feb; 37(1):47-53. PubMed ID: 27043320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
    Finger PT; Chin KJ; Semenova EA
    Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of choroidal thickness changes following intravitreal dexamethasone, ranibizumab, and triamcinolone in eyes with retinal vein occlusion.
    Yumusak E; Ornek K; Dikel NH
    Eur J Ophthalmol; 2016 Nov; 26(6):627-632. PubMed ID: 26847213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation maculopathy treated with intravitreal bevacizumab.
    Sánchez-Vicente JL; Muñoz-Morales A; Galván-Carrasco MP; Castilla-Lázpita A; Vital-Berral C; Alfaro-Juárez A; Rueda-Rueda T
    Arch Soc Esp Oftalmol; 2017 Jun; 92(6):283-286. PubMed ID: 27894518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INTRAVITREAL DEXAMETHASONE IMPLANT IN PATIENTS WITH RANIBIZUMAB PERSISTENT DIABETIC MACULAR EDEMA.
    Zhioua I; Semoun O; Lalloum F; Souied EH
    Retina; 2015 Jul; 35(7):1429-35. PubMed ID: 26102440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone intravitreal implants for diabetic macular edema refractory to ranibizumab monotherapy or combination therapy.
    Gutiérrez-Benítez L; Millan E; Arias L; Garcia P; Cobos E; Caminal M
    Arch Soc Esp Oftalmol; 2015 Oct; 90(10):475-80. PubMed ID: 26008920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Singer MA; Capone A; Dugel PU; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Apr; 15():33. PubMed ID: 25885285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.